Accepted at 11:54 p.m. Oct, 31, 2023 by dollajas
Author: alexanderchang1
Related Note: 1487116826422 2
Rationale for change

UWorld question 17446 tests this specific distinction, indicating it is important and also inadequately covered by the current two clozes.


Source regarding MHCII Extra note in addition to UWorld.
https://www.nature.com/articles/nri3818/figures/1

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
Empty field
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#OME::03_Immune::01_Immunology::05_APCs_and_MHCs #AK_Step1_v12::#NBME::24 #AK_Step1_v12::#UWorld::#UWSA3 #AK_Step1_v12::#UWorld::Step::17446 #AK_Step1_v12::#FirstAid::02_Immunology::02_Cellular_Components::03_Major_histocompatibility_complex_I_and_II #AK_Step1_v12::#UWorld::COMLEX::26620 #AK_Step1_v12::#UWorld::Step::11674 #AK_Step1_v12::#OME::PreClinical::03_Immune::01_Immunology::05_APCs_and_MHCs #AK_Step1_v12::#AMBOSS::1Ia2bN #AK_Step1_v12::#SketchyImmunology::03_The_Adaptive_Immune_System::02_Cell_Mediated_Immunity_(T-Cells)::02_Antigen_Processing_&_Presentation_to_T-Cells #AK_Step1_v12::#Low/HighYield::3-HighYield-temporary #AK_Step1_v12::^Systems::Immunology::MHC #AK_Step1_v12::^Other::^EXPN::Uworld #AK_Step1_v12::#Physeo::08_Immunology::01_Immunology::07_Major_Histocompatibility_Complexes #AK_Step1_v12::^Other::^EXPN::BGedit #AK_Step1_v12::#Pixorize::02_Immunology::04_B_Cells_&_T_Cells::01_MHC_I #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Immunology_+_General_Pathology::Immunology #AK_Step1_v12::#AMBOSS::ONaIYO #AK_Step1_v12::#UWorld::COMLEX::25611